Emens, L. A., Molinero, L., Loi, S., Rugo, H. S., Schneeweiss, A., Diéras, V., . . . Schmid, P. (2021). Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer: Biomarker evaluation of the IMpassion130 study. Journal of the National Cancer Institute, 113(8), . https://doi.org/10.1093/jnci/djab004
Chicago-Zitierstil (17. Ausg.)Emens, Leisha Ann, et al. "Atezolizumab and Nab-paclitaxel in Advanced Triple-negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study." Journal of the National Cancer Institute 113, no. 8 (2021). https://doi.org/10.1093/jnci/djab004.
MLA-Zitierstil (9. Ausg.)Emens, Leisha Ann, et al. "Atezolizumab and Nab-paclitaxel in Advanced Triple-negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study." Journal of the National Cancer Institute, vol. 113, no. 8, 2021, https://doi.org/10.1093/jnci/djab004.